Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies

BACKGROUND: In patients with Multiple Sclerosis (pwMS) disease-modifying therapies (DMTs) affects immune response to antigens. Therefore, post-vaccination serological assessments are needed to evaluate the effect of the vaccine on SARS-CoV-2 antibody response. METHODS: We designed a prospective mult...

Descripción completa

Detalles Bibliográficos
Autores principales: Sormani, Maria Pia, Inglese, Matilde, Schiavetti, Irene, Carmisciano, Luca, Laroni, Alice, Lapucci, Caterina, Da Rin, Giorgio, Serrati, Carlo, Gandoglia, Ilaria, Tassinari, Tiziana, Perego, Germana, Brichetto, Giampaolo, Gazzola, Paola, Mannironi, Antonio, Stromillo, Maria Laura, Cordioli, Cinzia, Landi, Doriana, Clerico, Marinella, Signoriello, Elisabetta, Frau, Jessica, Ferrò, Maria Teresa, Di Sapio, Alessia, Pasquali, Livia, Ulivelli, Monica, Marinelli, Fabiana, Callari, Graziella, Iodice, Rosa, Liberatore, Giuseppe, Caleri, Francesca, Repice, Anna Maria, Cordera, Susanna, Battaglia, Mario Alberto, Salvetti, Marco, Franciotta, Diego, Uccelli, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456129/
https://www.ncbi.nlm.nih.gov/pubmed/34563483
http://dx.doi.org/10.1016/j.ebiom.2021.103581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456129/
https://www.ncbi.nlm.nih.gov/pubmed/34563483
http://dx.doi.org/10.1016/j.ebiom.2021.103581

Ejemplares similares